Prognostic impact of RUNX1 mutations and deletions in pediatric acute myeloid leukemia: results from the French ELAM02 study group

Leukemia. 2023 Aug;37(8):1723-1726. doi: 10.1038/s41375-023-01931-y. Epub 2023 Jun 16.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Letter

MeSH terms

  • Child
  • Core Binding Factor Alpha 2 Subunit* / genetics
  • Humans
  • Leukemia, Myeloid, Acute* / genetics
  • Mutation
  • Prognosis

Substances

  • Core Binding Factor Alpha 2 Subunit
  • RUNX1 protein, human